Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07205328) titled 'A Clinical Trial of MT200605 for the Treatment of Acute Ischemic Stroke' on Sept. 25.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Shaanxi Micot Pharmaceutical Technology Co., Ltd.
Condition:
Acute Ischemic Stroke
Intervention:
Drug: MT200605
Drug: MT200605
Drug: MT200605
Recruitment Status: Recruiting
Phase: Phase 2
Date of First Enrollment: October 2025
Target Sample Size: 360
Countries of Recruitment:
China
To kno...